newsfilter
← Latest News
Business Wire·

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

New test brings quantitative cardiac assessment for cats and dogs into everyday workflows IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the launch of the